Email us: email@example.com
Current non-dynamic imaging techniques, have limitations:
Of the 40m mammograms per year in the US and over 1M biopsies, approximately two thirds (over 750,000 biopsies) are negative and potentially unnecessary.
The First Warning System™ (FWS) system uses a small data collection device placed under a bra to collect 12 hours of breast cell data (dynamic cell chaos). Circadian rhythm-based temperature variances of cell cycles are measured to identify abnormalities at the earliest stages of cell augmentation. Powerful predictive analytic software analyses the tissue data producing an object result to the physician to enable a sound and robust clinical decision from the physician and patient.
The power in the FWS is the predictive analytic software, CAPP (Computer Aided Physiological Profile), developed in conjunction with Nanyang Technological University and Lytix, Inc., the FWS employs a series of algorithms and neural networks to identify and categorize abnormal patterns in otherwise healthy cellular behavior within the breast delivering an accurate and reproducible automated result to the attending physician.
Transitional phases of metabolic development activity can be identified pathologically, genetically and biochemically. As normal cells begin the process of tumor generation, each phase exhibits a distinct, measurable, dynamic thermal chaos profile of tissue: normal, benign, suspicious, cancer in-situ and cancer.
Over 650 women tested in clinical trials have achieved promising results in sensitivity, specificity and accuracy (Positive Predictive Values) as compared to current screening modalities that are approximately 70% accurate with the disadvantages of compression, radiation and more narrow population applications. The FWS is preparing for a final validation round of a targeted clinical study to ensure reproducible results can be expected with the state-of-the art 4th generation device and software.